Differential expression of CIART in amyotrophic lateral sclerosis.
PreprintsShahan Mamoor
Shahan Mamoor
Shahan Mamoor
Shahan Mamoor
Julie Necarsulmer, Jeremy Simon, Baggio Evangelista, YouJun Chen, Xu Tian, Sara Nafees, Ariana Marquez Gonzalez, Ping Wang, Deepa Ajit, Viktoriya Nikolova, Kathryn Harper, Jennifer Ezzell, Adriana Beltran, Sheryl Moy,
Pedro Silva Couto, Sam A. Molina, Denis O’Sullivan, Liam O'Neill, Alexander M. Lyness, Qasim Rafiq
Vaishali Yadav, Papri Das, RamKrishna Mishra, Richa Arya
Alexandra Chrysanthou, Minerva Bosch-Fortea, Julien Gautrot
Qianqi Zhu, Miaoying Tan, Chengniu Wang, Yufei Chen, Chenfei Wang, Junqi Zhang, Yijun Gu, Yuqi Guo, Jianpeng Han, Lei Li, Rongrong Jiang, Xudong Fan, Huimin Xie, Liang Wang,
Richard C Chang, Erika M. Joloya, Zhuorui Li, Bassem M Shoucri, Toshi Shioda, Bruce Blumberg
Shahan Mamoor
Shahan Mamoor
Shahan Mamoor
Shahan Mamoor
Shahan Mamoor
Shahan Mamoor
Shahan Mamoor
Shahan Mamoor
Shahan Mamoor
Shahan Mamoor
Shahan Mamoor
Cedars-Sinai has been awarded a five-year, $8 million grant from California’s stem cell agency to launch an innovative new clinic that will expand patients’ access to stem cell and gene therapies, increase research and training in regenerative medicine, foster greater collaboration with eight similar clinics across the state and help educate the public about stem cell and related therapies.
In animal models, UC San Diego researchers found that intensive physical therapy in tandem with implanted neural stem cells increased tissue growth, repair and functionality in spinal cord injuries more than those treatments alone
Gaofeng Tang, Huibo Zhao, Guoyong Chen
Magdalena Harakalova, Jiayi Pei, Renee Maas, Karen Gaar-Humphreys, Johannes Gho, Emilia Nagyova, Christian Snijders Blok, Iris van Adrichem, René van Es, Shahrzad Sepehrkhouy, Dries Feyen, Noortje Van Den Dungen, Nico Lansu, Jorg Cal
Gurvir S Virdi, Minee Liane Choi, James R Evans, Zhi Yao, Dilan Athauda, Stephanie Strohbuecker, Anna I Wernick, Haya Alrashidi, Daniela Melandri, Jimena Perez-Lloret, Plamena R Stroh, Sergiy Sylantyev, Simon Eaton, Simon Heales,
Ting Fu, Fangzhi Lou, Qiang Zhu, Shuyu Cai, Shuanglin Peng, Jingang Xiao
Laura Regue, William Wang, Fei Ji, Joseph Avruch, Hua Wang, Ning Dai
Larissa Lipskaia, Marielle Bréau, Christelle Cayrou, Dmitri Churikov, Laura Braud, Charles Fouillade, Sandra Curras-Alonso, Serge Bauwens, Frederic Jourquin, Frederic Fiore, Rémy Castellano, Emmanuelle Josselin, Carlota Sánchez-Ferrer,
Ana Catarina Sousa, Sara Biscaia, Rui Alvites, Mariana Branquinho, Bruna Lopes, Patrícia Sousa, Joana Valente, Margarida Franco, José Domingos Santos, Carla Mendonça, Luís Atayde, Nuno Alves, Ana Colette Maurício
Augustas Pivoriūnas
Qing Lin, Yumei Yang, Xiaoyun Li, Haoyu Wang, Yan Cui, Panpan Wang, Xiaofeng Zhu, Li Yang, Ronghua Zhang
Liguo Jia, Zhenzhen Gao, Jing Chen
Andrea R. Daniel, Chang-Lung Lee, Chang Su, Nerissa T. Williams, Zhiguo Li, Jianguo Huang, Omar Lopez, Lixia Luo, Yan Ma, Lorraine De Silva Campos, Sara R. Selitsky, Jennifer L. Modliszewski, Siyao Liu, Yvonne M. Mowery,
Researchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) have used CRISPR/Cas9 technology to engineer donor T cells to try to treat seriously ill children with resistant leukemia, who had otherwise exhausted all available therapies.
Irvine, Calif., Oct. 27, 2022 — With a five-year, $8 million grant from the California Institute for Regenerative Medicine, the University of California, Irvine has earned designation as one of CIRM’s Alpha Clinics. The goal of the statewide network is to accelerate the development of promising stem cell and gene therapies and expand patient access to them through clinical trials approved by the U.
La Jolla Institute for Immunology (LJI) researchers have made a major breakthrough in understanding how deletion of the genes that encode TET proteins can lead to cancer growth.
Sanam Peyvandi, Manon Bulliard, Annamaria Kauzlaric, Oriana Coquoz, Yu-Ting Huang, Nathalie Duffey, Laetitia Gafner, Girieca Lorusso, Nadine Fournier, Qiang Lan, Curzio Rüegg
Alireza Yeganeh, Anwar Fathollahi, Seyed Mahmoud Hashemi, Farshid Yeganeh
Mandana Shirdarreh, Fatemeh Amiri, Mohammad Pouya Samiee, Armita Safari
Benjamin William Walters, Shannon R Rainsford, Nicolas Dias, Xiaofang Huang, Dirk G de Rooij, Bluma J Lesch
Hatef Ghasemi Hamidabadi, Sanaz Alizadeh, Leila Mahboobi, Zahra Khosrowpour, Maryam Nazm Bojnordi, Zahra Aliakbar Ahovan, Majid Malekzadeh Shafaroudi, Maria Zahiri, Narendra Pal Singh Chauhan, Mazaher Gholipourmalekabadi
Sheeba John, Federico Apelt, Amit Kumar, Dominik Bents, Maria Grazia Annunziata, Franziska Fichtner, Bernd Mueller-Roeber, Justyna J. Olas
Hao Liu, Ranli Gu, Wei Li, Lijun Zeng, Yuan Zhu, Siyi Wang, Xuenan Liu, Boon Chin Heng, Yunsong Liu, Yongsheng Zhou
Margarita E. Bogomiakova, Elizaveta K. Sekretova, Ksenia S. Anufrieva, Polina O. Khabarova, Anastasia N. Kazakova, Pavel A. Bobrovsky, Tatiana V. Grigoryeva, Artem V. Eremeev, Olga S. Lebedeva, Alexandra N. Bogomazova, Maria A. Lagarkova
Using a new stem-cell based model made from skin cells, scientists found the first direct evidence that Stargardt-related ABCA4 gene mutations affect a layer of cells in the eye called the retinal pigment epithelium (RPE).
Glycolipids, basically "fatty sweet" molecules, are a relatively unknown group of lipids. A new method developed by an Austrian team led by chemist Evelyn Rampler of the University of Vienna has now provided deeper insights into the functioning of certain glycolipids located on the surfaces of stem cells.
BACKGROUNDWound healing impairment is a dysfunction induced by hyperglycemia and its effect on endothelial precursor cells (EPCs) in type 2 diabetes mellitus. There is increasing evidence showing that exosomes (Exos) derived from adipose-derive
BACKGROUNDThe effects of inappropriate dietary calcium intake in early life on later obesity have not been fully elucidated. AIMTo raise the mechanism of maternal calcium intake on the multi-differentiation potential of mesenchymal stem cells
A Rice University lab is leading the effort to reveal potential threats to the efficacy and safety of therapies based on CRISPR-Cas9, the Nobel Prize-winning gene editing technique, even when it appears to be working as planned.